Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Rowlandmiller & PARTNERS.ADV

Rowlandmiller & PARTNERS.ADV boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 2,384 shares of the medical equipment provider’s stock after purchasing an additional 106 shares during the quarter. Rowlandmiller & PARTNERS.ADV’s holdings in Intuitive Surgical were worth $1,244,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Midwest Capital Advisors LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $54,000. World Equity Group Inc. lifted its stake in shares of Intuitive Surgical by 22.8% during the fourth quarter. World Equity Group Inc. now owns 512 shares of the medical equipment provider’s stock worth $267,000 after purchasing an additional 95 shares in the last quarter. MONECO Advisors LLC lifted its stake in shares of Intuitive Surgical by 8.1% during the fourth quarter. MONECO Advisors LLC now owns 1,129 shares of the medical equipment provider’s stock worth $589,000 after purchasing an additional 85 shares in the last quarter. Lansing Street Advisors lifted its stake in shares of Intuitive Surgical by 21.3% during the fourth quarter. Lansing Street Advisors now owns 586 shares of the medical equipment provider’s stock worth $306,000 after purchasing an additional 103 shares in the last quarter. Finally, Howard Capital Management Inc. lifted its stake in shares of Intuitive Surgical by 3.5% during the fourth quarter. Howard Capital Management Inc. now owns 10,293 shares of the medical equipment provider’s stock worth $5,373,000 after purchasing an additional 348 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.4 %

Shares of Intuitive Surgical stock opened at $591.79 on Monday. The firm has a market cap of $210.78 billion, a P/E ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a 50-day moving average price of $565.45 and a 200 day moving average price of $525.60.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 over the last three months. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Truist Financial boosted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.